A dramatic recovery in a patient initially expected to die of TTP & its complications
Thrombotic thrombocytopenic purpura (TTP) has a high fatality rate if not caught early and treated with plasmapheresis. When TTP patients present late in their sequelae with neuro symptoms, an elevated lactate dehydrogenase and systemic symptoms, there is a high mortality rate. This report describes...
Main Authors: | Jennifer Ogilvie, Jaskeerat Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Greater Baltimore Medical Center
2018-05-01
|
Series: | Journal of Community Hospital Internal Medicine Perspectives |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20009666.2018.1475186 |
Similar Items
-
Successful Treatment of Refractory Thrombotic Thrombocytopenic Purpura with Rituximab, a Monoclonal Antibody: a Case Report
by: M Pedram, et al.
Published: (2009-09-01) -
COVID‐19‐induced thrombotic microangiopathy: A great mimicker of thrombotic thrombocytopenic purpura (TTP)
by: Brian Warnecke, et al.
Published: (2023-01-01) -
Thrombotic thrombocytopenic purpura (TTP) or Moschowitz syndrome: a true hematologic emergency
by: Deborah Melis, et al.
Published: (2012-01-01) -
Thrombotic thrombocytopenic purpura in a patient with interferon treated hepatitis C successfully treated with Rituximab
by: Nishant Poddar, et al.
Published: (2013-01-01) -
Clinical characteristics, treatments, and outcomes of thrombotic thrombocytopenic purpura treated with plasma exchange in Japan: a nationwide inpatient database study
by: Yuji Yamada, et al.
Published: (2023-05-01)